Article
CXCR4 as a therapeutic target in acute myeloid leukemia.
Leukemia - 1 Nov 2024
Korbecki Jan, Bosiacki Mateusz, Kupnicka Patrycja, Barczak Katarzyna, Chlubek Dariusz, Baranowska-Bosiacka Irena
Abstract excerpt
Extensive research on the CXCL12-CXCR4 axis in acute myeloid leukemia (AML) has resulted in the incorporation of novel anti-leukemia drugs targeting this axis into therapeutic strategies. However, despite this progress, a comprehensive and up-to-date review addressing the role of the CXCL12-CXCR4 axis in AML's oncogenic processes is lacking. In this review, we examine its molecular aspects influencing cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
